Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection
F. Sampsonas, M. Lagadinou, T. Karampitsakos, E. Solomou, M. Doulberis, M. Marangos, A. Tzouvelekis Respiratory Medicine Department, University Hospital of Patras, Greece. fsampsonas@gmail.com
Severe Acute Respiratory Syndrome Corona Virus-2 is the causative factor of Coronavirus Disease 2019. Early in the pandemic, mediastinal lymphadenopathy was not considered to be a significant radiologic finding of the SARS-COV-2 disease. Nevertheless, most recent studies associate mediastinal lymphadenopathy with more severe COVID-19 disease and poorer patient outcomes.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
F. Sampsonas, M. Lagadinou, T. Karampitsakos, E. Solomou, M. Doulberis, M. Marangos, A. Tzouvelekis
Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 9
Pages: 3607-3609
DOI: 10.26355/eurrev_202105_25843